LumiraDx Limited (NASDAQ:LMDX) Q2 2023 Earnings Call Transcript August 24, 2023 8:30 AM ET

Company Participants

Melissa Garcia - Vice President Corporate Counsel

Ron Zwanziger - Chairman & Chief Executive Officer

Dorian LeBlanc - Chief Financial Officer

Conference Call Participants

Matt Sykes - Goldman Sachs

Jeffrey Cohen - Ladenburg Thalmann

Andrew Cooper - Raymond James

Mark Massaro - BTIG

Operator

Good day and thank you for standing by. Welcome to the LumiraDx Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions]. Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker today Melissa Garcia, Vice President, Corporate Counsel. Please begin.

Melissa Garcia

Hello everyone and welcome to today's call to discuss LumiraDx's second quarter 2023 financial results issued earlier today. Joining us are LumiraDx's Chairman and CEO, Ron Zwanziger; and Chief Financial Officer, Dorian LeBlanc. The press release announcing our financial results is posted on the Investor Relations section of the company's website at lumiradx.com.

Before we begin, I would like to caution listeners that any statements we make today, other than historical facts, are forward-looking statements made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Please be aware that all such forward-looking statements involve risks and uncertainties such as those detailed in our annual report on Form 20-F for the year ended December 31, 2022, which was filed with the SEC on May 1, 2023 and in other filings that we make with the SEC. Any forward-looking statements that we make must be considered in light of these factors. Actual results may vary materially.

Also, during today's call, we may refer to certain non-IFRS financial measures. Non-IFRS financial measures should not be considered in isolation from or as a substitute for financial information presented in compliance with IFRS. There is a schedule showing the reconciliation of these non-IFRS financial measures in our press release issued earlier today which can be found on our website at lumiradx.com.

I will now turn the call over to Ron Zwanziger for opening remarks and general business update. We will then provide financial updates before answering questions. Ron?

Ron Zwanziger

Thanks, Melissa. Good morning everyone and thank you for joining our second quarter results call. In the United States during Q2, we strategically positioned our North American business to take advantage of the upcoming respiratory season in the short-term, while also focusing on expanding our testing menu for both short-term and long-term growth.